# An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)

> **NCT01615068** · — · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 1007 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01615068
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-05
- **Primary completion:** 2017-11-16
- **Final completion:** 2017-11-16
- **Target enrollment:** 1007 (ACTUAL)
- **Last updated:** 2018-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01615068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01615068, "An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01615068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*